Corrigendum: mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression.
作者信息
Kon Ning, Ou Yang, Wang Shang-Jui, Li Huan, Rustgi Anil K, Gu Wei
出版信息
Genes Dev. 2021 Feb 1;35(3-4):300. doi: 10.1101/gad.348236.121.
Abstract
摘要
相似文献
1
Corrigendum: mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression.勘误：mTOR抑制在p53介导的肿瘤抑制中起到意外的检查点作用。
Genes Dev. 2021 Feb 1;35(3-4):300. doi: 10.1101/gad.348236.121.
2
As expected, based on rapamycin-like p53-mediated gerosuppression, mTOR inhibition acts as a checkpoint in p53-mediated tumor suppression.正如预期的那样，基于雷帕霉素样的p53介导的衰老抑制作用，mTOR抑制在p53介导的肿瘤抑制中起检查点的作用。
Oncoscience. 2022 Aug 30;9:38-41. doi: 10.18632/oncoscience.561. eCollection 2022.
3
Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.Notch1介导的生存信号通路：雷帕霉素哺乳动物靶点（mTOR）依赖性抑制p53
Cancer Res. 2006 May 1;66(9):4715-24. doi: 10.1158/0008-5472.CAN-05-3830.
4
A p53-independent G1 cell cycle checkpoint induced by the suppression of protein kinase C alpha and theta isoforms.蛋白激酶Cα和θ亚型的抑制诱导的不依赖p53的G1细胞周期检查点
J Biol Chem. 2003 Oct 10;278(41):39782-93. doi: 10.1074/jbc.M306854200. Epub 2003 Aug 1.
5
DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis.DNA损伤诱导的p53表达抑制有丝分裂检查点激酶hMps1：p53突变细胞中缺乏这种抑制作用会导致细胞凋亡。
J Biol Chem. 2006 Mar 31;281(13):8675-85. doi: 10.1074/jbc.M511333200. Epub 2006 Jan 30.
6
Stabilization of P/CAF, as a ubiquitin ligase toward MDM2, suppresses mitotic cell death through p53-p21 activation in HCT116 cells with SIRT2 suppression.作为一种针对 MDM2 的泛素连接酶，P/CAF 的稳定通过 SIRT2 抑制的 HCT116 细胞中的 p53-p21 激活抑制有丝分裂细胞死亡。
Biochem Biophys Res Commun. 2019 Jan 1;508(1):230-236. doi: 10.1016/j.bbrc.2018.11.136. Epub 2018 Nov 24.
7
p53 inhibition provides a pivotal protective effect against ischemia-reperfusion injury in vitro via mTOR signaling.p53抑制通过mTOR信号通路在体外对缺血再灌注损伤提供关键的保护作用。
Brain Res. 2015 Apr 24;1605:31-8. doi: 10.1016/j.brainres.2015.02.009. Epub 2015 Feb 12.
8
P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway.P53 通过抑制 PI3K/AKT/mTOR 通路抑制骨肉瘤的细胞增殖、转移和血管生成。
Int J Surg. 2015 Aug;20:80-7. doi: 10.1016/j.ijsu.2015.04.050. Epub 2015 Apr 30.
9
Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.雷帕霉素（mTOR 抑制剂）对不同 p53 基因状态肺癌细胞放射敏感性的影响。
Int J Oncol. 2010 Oct;37(4):1001-10. doi: 10.3892/ijo_00000751.
10
Dual inhibition of PI3K/Akt signaling and the DNA damage checkpoint in p53-deficient cells with strong survival signaling: implications for cancer therapy.在具有强大生存信号的p53缺陷细胞中对PI3K/Akt信号传导和DNA损伤检查点进行双重抑制：对癌症治疗的意义。
Cell Cycle. 2007 Sep 15;6(18):2268-75. doi: 10.4161/cc.6.18.4705. Epub 2007 Jul 5.
引用本文的文献
1
Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway.核受体调节剂通过调节 mTOR 信号通路抑制骨肉瘤细胞增殖和肿瘤生长。
Cell Death Dis. 2023 Jan 21;14(1):51. doi: 10.1038/s41419-022-05545-7.
2
Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.衰老相关特征可预测肝细胞癌的预后和免疫治疗疗效。
Front Immunol. 2022 Sep 15;13:951459. doi: 10.3389/fimmu.2022.951459. eCollection 2022.
3
The Antisenescence Effect of Exosomes from Human Adipose-Derived Stem Cells on Skin Fibroblasts.人脂肪来源干细胞外泌体对皮肤成纤维细胞的抗衰作用。
Biomed Res Int. 2022 Jun 29;2022:1034316. doi: 10.1155/2022/1034316. eCollection 2022.
4
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression.解析 p53 在转录调控和肿瘤抑制中的乙酰化密码。
Oncogene. 2022 May;41(22):3039-3050. doi: 10.1038/s41388-022-02331-9. Epub 2022 Apr 29.
Zotero 插件